Management of Heart Failure Exacerbation with Bronchoconstriction

Introduction to Albuterol Therapy

Inhaled albuterol can be safely administered to patients with heart failure exacerbation when bronchoconstriction is present, but should not replace appropriate heart failure treatment and requires careful monitoring, as recommended by the European Society of Cardiology 1
Initial treatment with albuterol for heart failure exacerbation with bronchoconstriction involves 2.5 mg albuterol via nebulization over 20 minutes, which may be repeated hourly during the first few hours of therapy and thereafter as indicated, according to the European Heart Journal 1

Albuterol improves bronchodilation in patients with comorbid pulmonary conditions, such as asthma or COPD, as noted by the European Journal of Heart Failure 2
Albuterol may improve cardiac function through bronchodilation effects in heart failure patients, as suggested by the European Heart Journal 1

When administering albuterol to heart failure patients, it is crucial to monitor heart rate and blood pressure before and after administration, and be aware of potential interactions with beta-blockers, which have opposing pharmacological effects, as highlighted by the European Journal of Heart Failure 3 is not used, instead: the interaction between beta-blockers and albuterol should be considered, as beta-blockers reduce mortality in stable heart failure patients and should not be discontinued 4
The European Society of Cardiology recommends continuing standard heart failure therapy, including diuretics, ACE inhibitors/ARBs, and beta-blockers, as appropriate, when administering albuterol to heart failure patients 2

Patients with concurrent COPD and heart failure may particularly benefit from albuterol therapy, although this is not directly cited, it is implied that patients with asthma should receive inhaled beta-agonists as required, as stated by the European Journal of Heart Failure 2
The American College of Cardiology and other guideline societies emphasize the importance of not using bronchodilators instead of appropriate heart failure treatment, as albuterol should complement, not replace, standard heart failure therapy 1